Compare MGYR & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGYR | EDAP |
|---|---|---|
| Founded | 1922 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.1M | 128.9M |
| IPO Year | 2021 | 1998 |
| Metric | MGYR | EDAP |
|---|---|---|
| Price | $17.40 | $4.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 2.2K | ★ 34.7K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | ★ 26.83 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | $35.34 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $15.22 | $1.21 |
| 52 Week High | $20.00 | $5.05 |
| Indicator | MGYR | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 47.16 | 68.79 |
| Support Level | $17.04 | $3.18 |
| Resistance Level | $17.99 | $4.32 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.01 | 0.12 |
| Stochastic Oscillator | 26.47 | 90.91 |
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.